Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,333 public trials 507 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +33 more
Locations
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Cancer Care Wollongong Wollongong, New South Wales, Australia
  • Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
View Trial Details
Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT05877599

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Santa Monica, California, United States
View all 18 locations
View Trial Details
Recruiting

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

NCT07444814

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • UCLA - Hematology/Oncology Clinical Research Unit Los Angeles, California, United States
  • St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

NCT06412120

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Broward Health Fort Lauderdale, Florida, United States
  • University of Florida Jacksonville Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Ahmadu Bello University Teaching Hospital (ABUTH) Zaria, Kaduna State, Nigeria
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

NCT07059884

Conditions
Adnexal Diseases, Anal Cancer, Anus Diseases, +82 more
Locations
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • Kaiser Permanente Fresno Orchard Plaza Fresno, California, United States
  • Kaiser Permanente-Modesto Modesto, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NCT06330064

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +55 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Pih Health Hematology Medical Oncology Whittier, California, United States
  • Orchard Healthcare Research Inc Skokie, Illinois, United States
View all 120 locations
View Trial Details
Recruiting

Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

NCT06476184

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • ICO Paul Papin Angers, France
  • CH d'Avignon Avignon, France
  • Sainte-Catherine Institut du Cancer Avignon-Provence Avignon, France
  • Hôpital de la Côte Basque Bayonne, France
View all 76 locations
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details

Related conditions